Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
BackgroundHelicobacter pylori (H. pylori) is highly prevalent worldwide and is closely associated with many gastric conditions. Current methods for eradicating H. pylori include triple or quadruple therapy, including antibiotics, proton pump inhibitors, and bismuth agents; however, with antibiotic a...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2025-02-01
|
| シリーズ: | Frontiers in Cellular and Infection Microbiology |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fcimb.2025.1441185/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|